|
|
| September 2, 2019: Dr. Kausik Ray and Dr. C. Michael Gibson Discuss: Impact of inclisiran on LDL-C over 18 months in patients with ASCVD or |
Dr. Kausik Ray and Dr. C. Michael Gibson Discuss: Impact of inclisiran on LDL-C over 18
months in patients with ASCVD or risk-equivalent – Results of the Phase 3 ORION-11 trial -
Sponsored by an independent educational grant from The Medicines Company
Sponsored by an independent educational grant from The Medicines Company
[ Download video ] |
|
No comments have been submitted
|